systems in human PD-related syndromes. How Do These New Models Compare They characterized five lines of mice that express normal levels of mouse ␣-syn plus 10%-80% of ␣-syn levels to Existing Models? Although work still needs to be done to fully characterize found in human brain. All of these transgenic strains developed neuronal cytoplasmic and nuclear inclusions both models, the major advantage over existing models is their chronic nature and the presence of ␣-syn incluthat stained with antibodies to human ␣-syn and ubiquitin. Nuclear inclusions are atypical in sporadic PD. The sions. The fact that expression of WT human ␣-syn elicits DA deficits, neuronal inclusions, and motor deficits inclusions seem to get larger with age, which may be consistent with a degenerative process. Electron miin species as diverse as fruit flies and mice makes it likely that the alterations induced in these animal models croscopy revealed electron-dense inclusions composed of fine granular material, although no fibrillar aggregaare also involved in the human disease. The fly model fulfills most of the criteria for an excellent PD model, tion, which is characteristic of Lewy bodies, was noted. There was no reported loss of DA neurons, however, including progression, age dependence, selective loss of DA neurons, and formation of fibrillar ␣-syn inclusions. in the 12-month-old high-expressing line there was a significant degeneration of DA nerve terminals. There
Although the present mouse model represents a significant advance, the fly model is quite compelling and were also decrements in the levels and catalytic activity of the rate-limiting enzyme of DA biosynthesis, tyrosine suggests that we should be able to develop a mouse that recapitulates sporadic PD more faithfully than the hydroxylase (TH), with an accompanying impairment in rotorod motor performance. It is difficult to say whether present model. Perhaps aging the ␣-syn transgenic mice beyond 1 year or increasing the level of neuronal oxidathe motor deficits are due to the small decrements in TH activity, as symptoms in PD patients and in the MPTP tive stress through pharmacological or genetic means will produce more significant pathology and DA cell loss. models develop after losing a critical threshold of 60% to 80% of striatal DA (Dunnett and Bjorklund, 1999) .
If we extrapolate the findings from Drosophila, we might need to examine mice that are significantly older than This should be readily addressable in future behavioral studies monitoring the response to DA replacement. one year. Alternatively, expressing higher levels of human WT ␣-syn or the mutant ␣-syn should produce Feany and Bender (2000) have developed a fruit fly model of PD associated with overexpression of ␣-syn. transgenic mice with a more severe phenotype. Do These Transgenic Models Teach Us Anything When normal and mutant forms of ␣-syn are overexpressed in Drosophila, the flies develop an adult-onset New about PD Pathogenesis? These models are quite persuasive in implicating ␣-syn (mid-life) progressive loss of DA neurons and filamentous intraneuronal inclusions that contain ␣-syn. The in the pathogenesis of PD. Due to the timing of ␣-syn inclusion formation in the fly, the process and/or formatransgenic flies also develop progressive age-dependent locomotor dysfunction. It is not yet known, whether tion of ␣-syn inclusions appear to be the cause of DA neuron cell death. The mouse model also teaches us the motor deficits of transgenic flies respond to DA replacement, but this should also be easily testable in that ␣-syn accumulation without the formation of fibrils leads to DA neuron dysfunction. ␣-syn inclusions are future studies as there are reliable ways to administer not restricted to DA neurons and yet none of these other neuronal subtypes show obvious degeneration. As yet, neither model yields any specific clues on how ␣-syn selectively injures or kills DA neurons. In particular, questions regarding the role of ␣-syn fibrils, protofibrils, oligomers, pale bodies, Lewy bodies, ubiquitination, and ␣-syn-interacting proteins in DA neuron cell death remain. Furthermore, the relationship and timing of oxidative stress and decrements in mitochondrial complex 1 to ␣-syn aggregation in sporadic PD remain to be shown. Whether microglia participate in ␣-syn-mediated DA neuron death is not known. However, the fly and mouse models should prove enormously useful in clarifying these complex issues. Suppressor and modifier screens in the fly could also identify important pathways involved in ␣-syn toxicity, which could be exploited for novel therapeutics in the treatment of PD.
